Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
395
datasets available to search
ShareScore release 0.9.0
Dataset results
395 results for “blood testing”
Future Blood Testing Network+ Overview and Recap - Dr Weizi (Vicky) Li
<p>This video is the first talk from our Future of Healthcare: Remote Blood Testing, Monitoring & AI Meeting that took place on 07-08/11/2023. </p><p>Future Blood Testing Network+ Overview and Recap - Dr Weizi (Vicky) Li (Henley Business School, University of Reading). </p><p>Bio: Weizi (Vicky) Li is a Professor of Informatics and Digital Health, Deputy Director in Informatics Research Centre, Henley Business School, University of Reading. She is a Fellow of Charted Institute of IT (British Computer Society). She is an interdisciplinary researcher focusing on using informatics, data science, machine learning, and digital information systems to solve real-world healthcare challenges. She is currently the Principal Investigator and Director of EPSRC Future Blood Testing for Inclusive Monitoring and Personalised Analytics NetworkPlus; and EPSRC AI for Health project: Advancing machine learning to achieve real-world early detection and personalised disease outcome prediction of inflammatory arthritis. She is the academic lead of a large collaborative project of Improving the Quality of Healthcare through an Integrated Clinical Pathway Management Approach and Cloud-based Digital Data Integration Platform, which was awarded ESRC O2RB Excellence in Impact Award in 2018 and 4*/3* impact case study in REF 2021 for her research impact on healthcare quality improvement. She is the academic lead of a machine learning-based decision support system for outpatient management which has successfully been implemented in Royal Berkshire NHS Foundation Trust and has received the Research Engagement and Impact award in 2020, shortlisted for 2022 impact award and Health Service Journal (HSJ) patient safety award. </p><p>Further details on this event can be found at: https://www.futurebloodtesting.org/fbtn2023 </p><p>This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1</p><p>YouTube Link: https://youtu.be/Fqqekmhg79Q?si=l74rXxTFMx42mEsV</p>
Standard Distributions of Blood Tests for Public Use
<p>This dataset is the distribution parameters obtained by approximating the distribution of blood test values taken from inpatients in a Japanese hospital by a lognormal distribution or an exponential distribution. </p> <p>The parameters P1, P2 and P3 of the lognormal distribution are used in the following equation.<br> P1*exp(-(ln(x/P2)/P3)^2)</p> <p>The parameters P1 and P2 of the exponential distribution are used in the following.<br> P1*exp(-P2*x)</p> <p>This file is CSV with UTF-8 charset, and the columns are as follows.</p> <p>---<br> Test name<br> Test name in Japanese<br> Unit of the value<br> Distribution type (LogNormal or Exp)<br> P1<br> P2<br> P3<br> P1 Error(1sigma)<br> P2 Error(1sigma)<br> P3 Error(1sigma)<br> Number of data points used to make this distribution<br> Bin width used to make the distribution<br> ---</p> <p>Any researchers can use this dataset without privacy issues.<br> CC BY-NC 4.0<br> </p>
Introduction to the Future Blood Testing Network Plus - Dr Weizi (Vicky) Li (Henley Business School, University of Reading)
<p>This video is the first talk from our Future Blood Testing Network Plus Launch that took place on the 23/11/2021.</p> <p>Network Introduction - Dr Weizi (Vicky) Li (Henley Business School, University of Reading).</p> <p>Bio: Dr Weizi (Vicky) Li is the PI of the Future Blood Testing Network, an Associate Professor of Informatics and Digital Health, Deputy Director in Informatics Research Centre, Henley Business School, University of Reading. She is an interdisciplinary researcher focusing on using informatics, data science, machine learning, and digital information systems to solve real-world healthcare challenges. She is the academic lead of a large collaborative project of Improving the Quality of Healthcare through an Integrated Clinical Pathway Management Approach and Cloud based Digital Data Integration Platform, which was awarded ESRC O2RB Excellence in Impact Award in 2018 for her research impact on healthcare quality improvement. She is the academic lead of machine learning based decision support system for outpatient management which has successfully been implemented in Royal Berkshire NHS Foundation Trust and has received Research Engagement and Impact award in 2020. She has been PI on projects funded by ESRC, EPSRC, The Health Foundation, NHS and companies, working on data-driven decision support systems that use real-world data (under privacy preserving framework) from multiple sources including Electronic Patient Record in acute, community hospital and primary care settings, remote health monitoring and patient reported outcomes to develop novel technologies (including AI based methods) to support clinical and operational decision makings in patient pathway.</p> <p>Further details on this event can be found at: https://futurebloodtesting.org/event/23-11-21-future-blood-testing-network-launch/ </p> <p>This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1</p> <p>YouTube Link: https://youtu.be/YuBsU3NDdB0</p>
"Tiny Test Tubes" for affordable microfluidic blood measurements at the point of need - Dr Alexander Edwards (University of Reading)
<p>This video is the tenth talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 14/09/2022.</p> <p>"Tiny Test Tubes" for affordable microfluidic blood measurements at the point of need - Dr Alexander Edwards (University of Reading)</p> <p>Bio: Al Edwards has a background in fundamental immunology combined with expertise in biochemical engineering, he is an interdisciplinary researcher focussed on solving current and future healthcare challenges using an engineering science approach that combines a range of fields from biology, biochemistry, chemistry and physics. He works at the interface between academic technology discovery and industrial development and have experience of both fundamental research and the commercialisation of new technology. The two main challenges he currently works on are the development of affordable microfluidics for clinical diagnostics and microbiology, and the engineering science of complex biologic therapeutics such as vaccines. Alexander's research is funded from a wide range of sources, including NIHR , EPSRC, SBRI Healthcare, the Wellcome Trust, Innovate UK and industry</p> <p>Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/</p> <p>This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1</p> <p>YouTube Link: https://youtu.be/21a78Vql8b0</p>
Unmet Clinical Needs and Case Studies in Blood Testing - Prof Bryant Lin and Dr. Kevin Chang (Stanford University)
<p>This video is the seventh talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022.</p> <p>Unmet Clinical Needs and Case Studies in Blood Testing - Prof Bryant Lin and Dr. Kevin Chang (Stanford University)</p> <p>Bio: Bryant Lin, MD, MEng is a primary care physician, educator and researcher. The cornerstone of Dr. Lin's work is keeping medicine focused on humans - patients, providers, families and trainees - and not lost in technology and algorithms. His research and educational interests span (1) Developing and testing novel medical technologies, (2) Improving the health of Asian populations with Precision and Population Health, and (3) Increasing expression and interconnections in the Health Community with the Humanities and Arts. After receiving his undergraduate and master's degrees in Electrical Engineering and Computer Science from MIT, he completed his MD and internal Medicine training at Tufts University School of Medicine and Tufts Medical Center. He came to Stanford to serve as a Research Fellow in Cardiac Electrophysiology and Biodesign Fellow where he learned to identify unmet human-centered needs. Since completing his post-graduate training, he stayed at Stanford as clinical faculty in Primary Care and Population Health in the Department of Medicine where he has invented and researched new medical technologies addressing unmet human-centered needs and started the Consultative Medicine Clinic evaluating patients with medical mysteries. He serves as the Training Director for the Joe and Linda Chlapaty DECIDE Center which has created a novel shared decision making tool for atrial fibrillation anticoagulation and is an investigator in several active clinical trials. Three years ago, he co-founded and currently co-directs, with Dr. Latha Palaniappan, the Center for Asian Health Research and Education (CARE) which aims to improve the health of Asians everywhere. Most recently, he has worked closely with the Medicine and the Muse leadership to help start the Stuck@Home concert series, the Stanford SoundWalk and the COVID Remembrance project. Dr. Lin has an active interest in storytelling and film-making. He co-directs an undergraduate seminar, MED 53Q “Storytelling in Medicine”, with Dr. Lauren Edwards and is working with a group of students on a documentary on end-of-life care at a JapaneseAmerican Senior Home in the Bay Area.</p> <p>Kevin Chang MD, MS, is a primary care physician. His focus in on patient care, population health and quality improvement, and medical education. He received his undergraduate degree and master's degree in biomedical engineering from Duke University and Stanford University respectively, and completed his MD at New York University, followed by his medical training at Stanford University. He has since stayed on at Stanford as clinical faculty in Primary Care and Population Health in the Department of Medicine, where he also serves as the co-director of the resident physician Internal Medicine clinic.</p> <p>Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/</p> <p>This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1</p> <p>YouTube Link: https://youtu.be/ozk1iJYC1yk</p>
Transforming the UK's diagnostics agenda after COVID-19 and grand challenges – Future Blood Testing Landscape report - Prof Dimitris Grammatopoulos (University Hospitals Coventry & Warwickshire, University of Warwick)
<p>This video is the second talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022.</p> <p>Transforming the UK’s diagnostics agenda after COVID-19 and grand challenges – Future Blood Testing Landscape report - Prof Dimitris Grammatopoulos (University Hospitals Coventry & Warwickshire, University of Warwick)</p> <p>Bio: Dimitris Grammatopoulos, PhD, FRCPath, is Professor of Molecular Medicine at Warwick Medical School and Consultant in Clinical Biochemistry and Molecular Diagnostics at the University Hospitals of Coventry and Warwickshire, NHS Trust, United Kingdom. He also leads the Novel Biomarkers theme of the Institute of Precision Diagnostics and Translational Medicine, Pathology-UHCW NHS Trust. where he combines clinical expertise in diagnostic laboratory medicine with a research track-record in application of cutting edge multidiscipline methodologies in routine clinical diagnostics. He received academic and clinical training in Newcastle, Bristol, Johns Hopkins-Baltimore and Warwick. He has expertise in biochemical/molecular diagnosis of many endocrine and metabolic disorders. His translational research interest is focused on stress hormones and homeostatic adaptations of fetal development to maternal disease as well as development of novel -omics based biomarker approaches suitable for precision medicine and better characterisation of patient phenotype. He has experience around use of AI and ML for development and refinement of clinical and diagnostic pathways for complex chronic conditions that are considered as national priorities. Dimitris is the Lead in Diagnostics, Global Health Priorities in Health, University of Warwick.</p> <p>Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/</p> <p>This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1</p> <p>YouTube Link: https://youtu.be/HiOlRzJPR7Q</p>
Future Blood Testing Network+ Overview - Dr Weizi (Vicky) Li (Henley Business School, University of Reading).
<p>This video is the first talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022.</p> <p>Future Blood Testing Network+ Overview - Dr Weizi (Vicky) Li (Henley Business School, University of Reading).</p> <p>Bio: Dr Weizi (Vicky) Li is the PI of the Future Blood Testing Network, an Associate Professor of Informatics and Digital Health, Deputy Director in Informatics Research Centre, Henley Business School, University of Reading. She is an interdisciplinary researcher focusing on using informatics, data science, machine learning, and digital information systems to solve real-world healthcare challenges. She is the academic lead of a large collaborative project of Improving the Quality of Healthcare through an Integrated Clinical Pathway Management Approach and Cloud based Digital Data Integration Platform, which was awarded ESRC O2RB Excellence in Impact Award in 2018 for her research impact on healthcare quality improvement. She is the academic lead of machine learning based decision support system for outpatient management which has successfully been implemented in Royal Berkshire NHS Foundation Trust and has received Research Engagement and Impact award in 2020. She has been PI on projects funded by ESRC, EPSRC, The Health Foundation, NHS and companies, working on data-driven decision support systems that use real-world data (under privacy preserving framework) from multiple sources including Electronic Patient Record in acute, community hospital and primary care settings, remote health monitoring and patient reported outcomes to develop novel technologies (including AI based methods) to support clinical and operational decision makings in patient pathway.</p> <p>Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/</p> <p>This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1</p> <p>YouTube Link: https://youtu.be/I1xsig9C8w0</p>
Improving triaging from primary care into secondary care using heterogeneous data-driven hybrid machine learning: A real-world case study of decision support system using blood test & GP referral letters - Bing Wang and Prof Weizi (Vicky) Li (University of Reading)
<p>This video is the sixth talk from our two day Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022.</p> <p>Improving triaging from primary care into secondary care using heterogeneous data-driven hybrid machine learning: A real-world case study of decision support system using blood test & GP referral letters - Bing Wang and Prof Weizi (Vicky) Li (University of Reading)</p> <p>Bio: Dr Weizi (Vicky) Li is the PI of the Future Blood Testing Network, an Associate Professor of Informatics and Digital Health, Deputy Director in Informatics Research Centre, Henley Business School, University of Reading. She is an interdisciplinary researcher focusing on using informatics, data science, machine learning, and digital information systems to solve real-world healthcare challenges. She is the academic lead of a large collaborative project of Improving the Quality of Healthcare through an Integrated Clinical Pathway Management Approach and Cloud based Digital Data Integration Platform, which was awarded ESRC O2RB Excellence in Impact Award in 2018 for her research impact on healthcare quality improvement. She is the academic lead of machine learning based decision support system for outpatient management which has successfully been implemented in Royal Berkshire NHS Foundation Trust and has received Research Engagement and Impact award in 2020. She has been PI on projects funded by ESRC, EPSRC, The Health Foundation, NHS and companies, working on data-driven decision support systems that use real-world data (under privacy preserving framework) from multiple sources including Electronic Patient Record in acute, community hospital and primary care settings, remote health monitoring and patient reported outcomes to develop novel technologies (including AI based methods) to support clinical and operational decision makings in patient pathway. Bing Wang is currently a PhD candidate in informatics and system science at the Informatics Research Center, Henley Business School, University of Reading. Bing’s research interests are Natural Language Processing, Machine Learning and Graph Machine Learning. Bing been working as a data scientist at Royal Berkshire NHS Foundation Trust since December 2019 during his PhD.</p> <p>Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/</p> <p>This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1</p> <p>YouTube Link: https://youtu.be/W6EH5l80NmU</p>
How to collect dried blood spot samples for hepatitis C testing (Spanish: Cómo obtener muestras de gota de sangre seca para el cribado de la hepatitis C)
<p>Short video in Spanish describing how to collect, store and ship to the laboratory, dried blood spot (DBS) samples for hepatitis C virus (HCV) testing.</p> <p>With proper training of the staff involved, DBS samples can be collected outside the healthcare setting, thus facilitating access to diagnosis of hepatitis C by the most vulnerable populations who attend different centers in the community.<br> With our experience in detecting HCV RNA from DBS samples since 2015, we have produced an explanatory video and a booklet with step-by-step instructions on how to obtain good quality DBS samples for laboratory HCV testing.<br> DBS samples not only allow us to improve the diagnosis rate of viremic HCV infection, but also to monitor the elimination of hepatitis C. Within the following website you can see the publications of different studies that we have carried out using DBS, which have also helped us to characterize the HCV epidemic at the local level.</p> <p>https://www.researchgate.net/project/Development-and-assessment-of-alternative-testing-strategies-for-the-detection-of-active-hepatitis-C-virus-infection-among-vulnerable-groups-at-risk-and-micro-elimination/update/61011c48647f3906fc8c31b8</p> <p> </p>
Future Blood Testing: Challenges & Opportunities
<p>This video shows the highlights of our Future Blood Testing: Challenges & Opportunities Event that took place on the 13/09/2022.</p> <p>Further details on this event can be found at: https://futurebloodtesting.org/event/13-14-09-2022/</p> <p>This video is an output from the Future Blood Testing Network which is funded by EPSRC under Grant Number EP/W000652/1 Music Licensing details: ASLC-1E1DFFF8-153AD9FEF0 The music is from Adobe Music, is called GUITAR-EPIC-TRAILER-VOCAL_AdobeStock_511629251</p> <p>YouTube Link: https://youtu.be/OfRa31Wvix8</p>
Effect of Direct-from-blood Bacterial Testing on Antibiotic Administration and Clinical Outcomes
ClinicalTrials.gov study NCT06069206. IPD Sharing: YES. Countries: 1. Publications: 18.
Distribution of blood flow oscillation across the Doppler shift evaluated by the proposed approach with local pressure test.
<p>A step-wise increase in local pressure is known to cause a gradual change in the parameters of capillary blood flow in the<br> upper layers of the skin, and can also affect the measurement results of various optical methods. The impact of the procedure has several subsequent effects, such as mechanical compression of vessels, and neurological and metabolic compensating mechanisms like pressure-induced vasodilation, which maintain the homeostasis of the skin during moderate levels of external pressure and tissue hypoxia. To examine how those effects are translated to the blood flow registering in different ranges of the Doppler spectra, we have developed a 3D-printed pressure distribution tool compatible with the developed sensor which was used, and equipped with a set of weights. </p> <p>During the main series of measurements, the weights were placed into the PDT in a step-wise manner to achieve the<br> following values of pressure applied: 10 mmHg, 30 mmHg, 90 mmHg, 150 mmHg, 210 mmHg. At the end of the procedure, the load was reduced back to 30 mmHg. Experiments were conducted with the participation of 7 healthy volunteers with 10 min LDF recording for each step. To estimate the prominence of the observed effects and substantiate the measuring routing, several preliminary experiments were also conducted where the set of values of pressure was applied with a step-wise increase and then decrease with about 2 min of LDF recordings for each step.</p> <p>Published in IEEE Transactions on Biomedical Engineering "Diagnosis of skin vascular complications revealed by time-frequency analysis and laser Doppler spectrum decomposition", Zherebtsov et al.</p>
PLINK association test statistics of UK Biobank blood traits
<p>PLINK association test statistics of UK Biobank blood traits generated for mvSuSiE fine-mapping analyses; see https://www.biorxiv.org/content/10.1101/2023.04.14.536893.</p>
Manipulation of Breath Alcohol Tests: Can Specific Techniques Alter Blood Alcohol Concentration Readings?
ClinicalTrials.gov study NCT02580318. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Validation of a Diagnostic Test for Glucose-6-phosphate Dehydrogenase (G6PD) Deficiency in Anti-coagulated Blood
ClinicalTrials.gov study NCT04054661. IPD Sharing: NO. Countries: 1. Publications: 1.
Screening With a DNA Blood Test to Address Colorectal Cancer Inequities
ClinicalTrials.gov study NCT06929481. IPD Sharing: NO. Countries: 1. Publications: 19.
Effect of Red Blood Cell Survival on a Commonly Used Diabetes Lab Test-HbA1c
ClinicalTrials.gov study NCT01204216. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Dried Blood Spot Test to Assess TB in Pregnancy
ClinicalTrials.gov study NCT04871230. IPD Sharing: UNDECIDED. Countries: 1. Publications: 6.
A Study to Test Whether ZS (Sodium Zirconium Cyclosilicate) Can Reduce the Incidence of Increased Blood Potassium Levels Among Dialized Patients.
ClinicalTrials.gov study NCT03303521. IPD Sharing: Not stated. Countries: 4. Publications: 2.
A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Liver Problems
ClinicalTrials.gov study NCT05731895. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.